SELLAS Life Sciences
SLS
#4150
Rank
โ‚ฌ2.53 B
Marketcap
12,45ย โ‚ฌ
Share price
-8.08%
Change (1 day)
837.33%
Change (1 year)

Earnings for SELLAS Life Sciences (SLS)

Earnings in 2026 (TTM): -โ‚ฌ30.37 Million

According to SELLAS Life Sciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ25.78 Million, an increase over its 2024 earnings that were of -โ‚ฌ28.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SELLAS Life Sciences from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ30.37 Million17.83%
2025 -โ‚ฌ25.78 Million-10.28%
2024 -โ‚ฌ28.73 Million-16.78%
2023 -โ‚ฌ34.53 Million-9.73%
2022 -โ‚ฌ38.25 Million65.85%
2021 -โ‚ฌ23.06 Million48.95%
2020 -โ‚ฌ15.49 Million-1.31%
2019 -โ‚ฌ15.69 Million-44.65%
2018 -โ‚ฌ28.35 Million45.99%
2017 -โ‚ฌ19.42 Million-33.17%
2016 -โ‚ฌ29.05 Million-6.87%
2015 -โ‚ฌ31.2 Million-30.98%
2014 -โ‚ฌ45.2 Million46.52%
2013 -โ‚ฌ30.85 Million
2011 -โ‚ฌ15.32 Million
2008 -โ‚ฌ13.27 Million27.51%
2007 -โ‚ฌ10.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion 343.33%๐Ÿ‡บ๐Ÿ‡ธ USA